trending Market Intelligence /marketintelligence/en/news-insights/trending/hgo7nzwlgzrxuftkhgdaca2 content esgSubNav
In This List

Sarepta Therapeutics appoints chief medical officer

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Sarepta Therapeutics appoints chief medical officer

Sarepta Therapeutics Inc. appointed Gilmore O'Neill as chief medical officer.

Most recently, O'Neill served as senior vice president of Biogen Inc. responsible for all late-stage clinical development.

Cambridge, Mass.-based Sarepta is a biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare neuromuscular diseases.